Literature DB >> 23192929

Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion.

Fabian Klostermann, Constanze Jugel, Miriam Bömelburg, Frank Marzinzik, Georg Ebersbach, Thomas Müller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23192929     DOI： 10.1002/mds.25238

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  11 in total

Review 1.  Therapy for Parkinson's disease: what is in the pipeline?

Authors:  Fabrizio Stocchi
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

2.  The Long Way of a "Lost Pigtail": A Unique Complication of J-Tube in Duodopa Therapy.

Authors:  Giovanni Cossu; Marianna Sarchioto; Marta Melis; Davide Manca; Loredana Sitzia; Maurizio Melis; Pierpaolo Carreras
Journal:  Mov Disord Clin Pract       Date:  2017-10-26

Review 3.  Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.

Authors:  Johan Virhammar; Dag Nyholm
Journal:  Ther Adv Neurol Disord       Date:  2016-12-01       Impact factor: 6.570

4.  Fistulization of J-PEG Jejunal Tube into the Colon in a Patient Treated with Duodopa® Infusion: A Case Report.

Authors:  Pedro Russo; Mariana Costa; Mário Silva; Ary de Sousa; Diana Carvalho; Joana Saiote; Milena Mendes
Journal:  GE Port J Gastroenterol       Date:  2017-01-19

Review 5.  Catechol-O-methyltransferase inhibitors in Parkinson's disease.

Authors:  Thomas Müller
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

6.  Acalculous cholecystitis associated with levodopa-carbidopa intestinal infusion therapy: A case report.

Authors:  Viviana Torres; Guillermo González-Ortega; Antoni Suárez; Alicia Garrido; Ana Cámara; Yaroslau Compta; Francesc Valldeoriola
Journal:  Clin Park Relat Disord       Date:  2022-07-01

Review 7.  Improving the Delivery of Levodopa in Parkinson's Disease: A Review of Approved and Emerging Therapies.

Authors:  Daniele Urso; K Ray Chaudhuri; Mubasher A Qamar; Peter Jenner
Journal:  CNS Drugs       Date:  2020-11-04       Impact factor: 5.749

Review 8.  The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review.

Authors:  Angelo Antonini; Per Odin; Rajesh Pahwa; Jason Aldred; Ali Alobaidi; Yash J Jalundhwala; Pavnit Kukreja; Lars Bergmann; Sushmitha Inguva; Yanjun Bao; K Ray Chaudhuri
Journal:  Adv Ther       Date:  2021-05-20       Impact factor: 3.845

9.  An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients.

Authors:  Rejko Krüger; Paul Lingor; Triantafyllos Doskas; Johanna M L Henselmans; Erik H Danielsen; Oriol de Fabregues; Alessandro Stefani; Sven-Christian Sensken; Juan Carlos Parra; Koray Onuk; Ashley Yegin; Angelo Antonini
Journal:  Adv Ther       Date:  2017-06-19       Impact factor: 3.845

10.  Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.

Authors:  Marianne Udd; Jukka Lyytinen; Johanna Eerola-Rautio; Anu Kenttämies; Outi Lindström; Leena Kylänpää; Eero Pekkonen
Journal:  Brain Behav       Date:  2017-06-05       Impact factor: 2.708
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.